TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Leo Pharma AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
106,094
|
103,139
|
105,491 |
| Financial expenses |
1,937
|
2,565
|
1,553 |
| Earnings before taxes |
3,403
|
2,820
|
4,140 |
| EBITDA |
4,114
|
3,980
|
4,374 |
| Total assets |
59,578
|
67,956
|
88,371 |
| Current assets |
56,734
|
63,758
|
83,069 |
| Current liabilities |
24,608
|
40,032
|
54,700 |
| Equity capital |
23,893
|
22,114
|
19,922 |
| - share capital |
649
|
672
|
668 |
| Employees (average) |
21
|
23
|
18 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
40.1%
|
32.5%
|
22.5% |
| Turnover per employee |
5,052
|
4,484
|
5,861 |
| Profit as a percentage of turnover |
3.2%
|
2.7%
|
3.9% |
| Return on assets (ROA) |
9.0%
|
7.9%
|
6.4% |
| Current ratio |
230.6%
|
159.3%
|
151.9% |
| Return on equity (ROE) |
14.2%
|
12.8%
|
20.8% |
| Change turnover |
6,367
|
-2,895
|
-10,360 |
| Change turnover % |
6%
|
-3%
|
-9% |
| Chg. No. of employees |
-2
|
5
|
-13 |
| Chg. No. of employees % |
-9%
|
28%
|
-42% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.